|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/427 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61K 38/05 | (2006.01) | ||
| A61P 17/06 | (2006.01) |
| (11) | Number of the document | 2934521 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12812221.5 |
| Date of filing the European patent application | 2012-12-19 | |
| (97) | Date of publication of the European application | 2015-10-28 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-30 |
| (46) | Date of publication of the claims translation | 2016-12-27 |
| (86) | Number | PCT/EP2012/076088 |
| Date | 2012-12-19 |
| (87) | Number | WO 2014/094840 |
| Date | 2014-06-26 |
| (72) |
CASERINI, Maurizio, IT
MAILLAND, Federico, CH
|
| (73) |
Polichem SA,
50, Val Fleuri, 1526 Luxembourg,
LU
|
| (74) |
Tatjana STERLINA,
UAB "Intels", Naugarduko g. 32/2, LT-03225 Vilnius,
LT
|
| (54) | Pidotimodo panaudojimas psoriazės gydymui |
| USE OF PIDOTIMOD TO TREAT PSORIASIS |
| Payment date | Validity (years) | Amount | |
| 2016-12-14 | 5 | 115.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-12-19 |